Your browser doesn't support javascript.
loading
NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson's disease using convolutional neural network.
Gaurav, Rahul; Valabrègue, Romain; Yahia-Chérif, Lydia; Mangone, Graziella; Narayanan, Sridar; Arnulf, Isabelle; Vidailhet, Marie; Corvol, Jean-Christophe; Lehéricy, Stéphane.
Afiliación
  • Gaurav R; Paris Brain Institute - ICM, Sorbonne University, UPMC Univ Paris 06, INSERM U1127, CNRS UMR 7225, Pitié-Salpêtrière Hospital, Paris, France; Movement Investigations and Therapeutics Team (MOV'IT), ICM, Paris, France; Center for NeuroImaging Research - CENIR, ICM, Paris, France. Electronic address:
  • Valabrègue R; Paris Brain Institute - ICM, Sorbonne University, UPMC Univ Paris 06, INSERM U1127, CNRS UMR 7225, Pitié-Salpêtrière Hospital, Paris, France; Center for NeuroImaging Research - CENIR, ICM, Paris, France.
  • Yahia-Chérif L; Paris Brain Institute - ICM, Sorbonne University, UPMC Univ Paris 06, INSERM U1127, CNRS UMR 7225, Pitié-Salpêtrière Hospital, Paris, France; Center for NeuroImaging Research - CENIR, ICM, Paris, France.
  • Mangone G; Paris Brain Institute - ICM, Sorbonne University, UPMC Univ Paris 06, INSERM U1127, CNRS UMR 7225, Pitié-Salpêtrière Hospital, Paris, France; INSERM, Clinical Investigation Center for Neurosciences (CIC), Pitié-Salpêtrière Hospital, Paris, France.
  • Narayanan S; McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, Quebec, H3A 2B4, Canada.
  • Arnulf I; Paris Brain Institute - ICM, Sorbonne University, UPMC Univ Paris 06, INSERM U1127, CNRS UMR 7225, Pitié-Salpêtrière Hospital, Paris, France; Movement Investigations and Therapeutics Team (MOV'IT), ICM, Paris, France; Sleep Disorders Unit, Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
  • Vidailhet M; Paris Brain Institute - ICM, Sorbonne University, UPMC Univ Paris 06, INSERM U1127, CNRS UMR 7225, Pitié-Salpêtrière Hospital, Paris, France; Movement Investigations and Therapeutics Team (MOV'IT), ICM, Paris, France; Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
  • Corvol JC; Paris Brain Institute - ICM, Sorbonne University, UPMC Univ Paris 06, INSERM U1127, CNRS UMR 7225, Pitié-Salpêtrière Hospital, Paris, France; INSERM, Clinical Investigation Center for Neurosciences (CIC), Pitié-Salpêtrière Hospital, Paris, France; Department of Neurology, Pitié-Salpêtrière Hospital,
  • Lehéricy S; Paris Brain Institute - ICM, Sorbonne University, UPMC Univ Paris 06, INSERM U1127, CNRS UMR 7225, Pitié-Salpêtrière Hospital, Paris, France; Movement Investigations and Therapeutics Team (MOV'IT), ICM, Paris, France; Center for NeuroImaging Research - CENIR, ICM, Paris, France; Department of Neuror
Neuroimage Clin ; 36: 103250, 2022.
Article en En | MEDLINE | ID: mdl-36451356
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Neuroimage Clin Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Neuroimage Clin Año: 2022 Tipo del documento: Article